Particulars |
|
|
|
Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
350.50 |
Sales(₹ Cr.) |
10,933.30 |
NP (₹ Cr.) |
1,741.31 |
NP Var (%) |
-11.00 |
Div% |
0.00 |
CPS(₹) |
34.80 |
EPS (₹) |
29.70 |
Traded Value(₹ Lakhs) |
1,192.10 |
52 Week High |
1,593.00 |
52 Week Low |
994.00 |
Price BSE |
1,028.00 |
Price NSE |
1,028.00 |
Market Capital (₹ Cr.) |
60,216.91 |
P/C Ratio |
29.50 |
P/E Ratio |
34.60 |
Price Vs.BV |
2.93 |
|
Latest Quarter |
Year End |
202506 |
Sales (₹ Cr.) |
2,822.14 |
NP(₹ Cr.) |
559.13 |
NP Var % |
70.00 |
Trailing Twelve Months |
Year End |
202506 |
Sales |
10,713.37 |
OPM |
23.11 |
NP |
2,069.02 |
NP Var (%) |
3.44 |
EPS |
33.74 |
PE |
30.46 |
|
|